Latest
AK74
Drug Czar's Office Admits that Drug Enforcement Can't Be Proven to Work
Trying to find a link between drug use and drug enforcement doesn't make sense, said Tom Riley, spokesman for the U.S. Office of National Drug Control Policy in Washington. "The U.S. has high crime rates but we spend a lot on law enforcement and prison,'' Riley said yesterday in a telephone interview. "Should we spend less? We're just a different kind of country. We have higher drug use rates, a higher crime rate, many things that go with a highly free and mobile society."
It is just an incredibly strange argument to emerge from the very people who've tirelessly defended the efficacy of law-enforcement as an essential component of our drug policy. I mean seriously, what on earth is he trying to say? Moreover, who are they to boast about our "highly free and mobile society" presiding as they do over our nation's largest campaign to reduce American freedom? There's no freedom or mobility for the 500,000 Americans they've banished behind bars for drug crimes. We wouldn't even have the "higher crime rate" he speaks of if we didnât make crimes of things that shouldnât be.
When I first learned of the new World Health Organization data showing that Americans use marijuana and cocaine at dramatically higher rates than the Netherlands, I asked myself how the Drug Czar's office could even begin to respond. It's a point they've been dodging for decades, thrust suddenly upon them in the form of a credible study that focuses directly upon that which they've sought so desperately to disregard. Nonetheless, I am honestly surprised that, in their infinite slipperiness, they couldn't come up with something better than this.
With the World's Highest Drug Use Rates, Our Fraudulent Drug Policy is Fully Exposed
Despite tough anti-drug laws, a new survey shows the U.S. has the highest level of illegal drug use in the world.
The World Health Organization's survey of legal and illegal drug use in 17 countries, including the Netherlands and other countries with less stringent drug laws, shows Americans report the highest level of cocaine and marijuana use.
For example, Americans were four times more likely to report using cocaine in their lifetime than the next closest country, New Zealand (16% vs. 4%),
Marijuana use was more widely reported worldwide, and the U.S. also had the highest rate of use at 42.4% compared with 41.9% of New Zealanders.
In contrast, in the Netherlands, which has more liberal drug policies than the U.S., only 1.9% of people reported cocaine use and 19.8% reported marijuana use. [CBSNews]
As Jacob Sullum points out:
â¦it's striking that the lifetime marijuana use rate in the U.S. (42.4 percent) is more than twice as high as the rate in the Netherlands (19.8 percent), despite the latter country's famously (or notoriously, depending on your perspective) tolerant cannabis policies. The difference for lifetime cocaine use is even bigger: The U.S. rate (16.2 percent) is eight times the Dutch rate (1.9 percet).
The Drug Czar's kneejerk description of Dutch drug policy as a raging trainwreck is thoroughly annihilated for everyone to see, and there's really just nothing else to say about it. Other countries are achieving much more desirable outcomes without incurring the massive social and fiscal costs of our towering war on drugs. Admittedly, Americans may possess a unique predisposition to enjoy these substances, but that's exactly the point; the more drugs we use, the greater the consequences if our policy towards drug use utterly sucks.
Americans for Safe Access: July 2008 Activist Newsletter
Student Members of AMA Endorse Access to Medical Marijuana
Resolution Goes to Full American Medical Association for November Vote
The prestigious American Medical Association (AMA) will consider endorsing therapeutic use of cannabis at its next interim meeting in November.
In June, the Medical Student Section (MSS) of the AMA, led by an ASA medical advisor, approved a resolution urging the physicians group to support the reclassification of marijuana for medical use. The MSS will send the resolution to the AMA House of Delegates for a final vote in November.
"While it is an historic occasion for any section of the AMA to endorse medical marijuana, the MSS is merely affirming existing science and urging the adoption of a sensible medical marijuana policy," said AMA-MSS member Sunil Aggarwal, who serves on ASA's Medical and Scientific Advisory Board and is pushing the effort to gain AMA endorsement. "As a future medical doctor, I look forward to exploring and utilizing the many medical benefits of cannabinoid medicines in patient care."
With nearly 50,000 members, the MSS is the largest and most influential organization of medical students in the United States.
"This is a positive and necessary step in the right direction," said Dr. David Ostrow, a member of the AMA and Chair of ASA's Medical and Scientific Advisory Board. "We are hopeful that the full house of delegates will follow the example set by the American College of Physicians and place the needs and safety of our patients above politics."
In February, the American College of Physicians (ACP) adopted a resolution that called for rescheduling marijuana to make it available by prescription and expanding research into its medical efficacy. With 124,000 members, the ACP is the country's second largest physician group and the largest organization of doctors of internal medicine.
Since 1996, twelve U.S. states have adopted medical marijuana laws. Public opinion polls consistently show that as many as 4 out of 5 Americans support access to medical marijuana.
The AMA-MSS resolution is online here.
ASA Fights Counties' Challenge to Calif. Medical Cannabis Law
Joins ACLU and State AG in Arguing Appeal of ID Card Ruling
Two California counties faced off against ASA, the ACLU and the state attorney general in appeals court last month, arguing whether the state's medical cannabis law should be enforced. San Diego and San Bernardino counties do not want to implement California's patient ID program and are appealing a superior court ruling that said they must.
ASA Chief Counsel Joe Elford
In an unusual move by the justices, an overflow room was set up with television coverage from the courtroom to accommodate the extraordinary turnout in court to hear oral arguments from ASA Chief Counsel Joe Elford, Adam Wolfe of the American Civil Liberties Union and Deputy Attorney General Peter Krause.
The counties are contending that federal law preempts California's medical marijuana laws. San Bernardino also argues that when the legislature added the card program they unconstitutionally amend the 1996 initiative enacted by voters.
Attorneys for patients told the justices that they should affirm the lower court ruling that California's decision not to arrest or prosecute medical marijuana patients is valid, even if the federal government prohibits all marijuana use.
"States have traditionally been entrusted with caring for the health and welfare of their citizens," said ASA's Elford. "Proper implementation of California's medical marijuana laws benefits patients, law enforcement, and the entire state."
The case is the result of the November 2005 vote by San Diego County Board of Supervisors to challenge the legislature's patient ID card program, a move that was joined by two others, San Bernardino and Merced. Merced agreed to implement the program after it lost the case in November 2006.
"San Diego and San Bernardino Counties remain intent on defying the will of California's voters and the well-being of thousands of sick and dying patients at tremendous taxpayer expense," said Adam Wolf, the ACLU attorney. "The counties' legally dubious lawsuit is a slap in the face to medical marijuana patients and the voters of California."
A ruling in the case from the California 4th District Court of Appeal is expected later this summer.
Additional information on the case is available online here.
ASA Chapter Focus: Western North Carolina
Among the affiliates of Americans for Safe Access enjoying recent success in defending patient rights is the Western North Carolina chapter, ASAWNC. Chapter members testified last month before the state legislature in support of making medical use legal in North Carolina, and the director's caregiver prevailed in an important court case.
On June 25, ASAWNC members traveled across the state to the capitol in Raleigh for the North Carolina House Science & Technology committee hearing regarding NC H.R. 2405, which is a bill to study the public benefits of allowing medical marijuana in the state. Joining ASAWNC director Jean Marlowe in testifying before the committee in support of the bill was former Surgeon-General Dr. Jocelyn Elders, as well as Dr. Laura Hanson of Chapel Hill and patient Dixie Deerman, who is a Registered Nurse in Asheville.
That testimony came just two days after Steve Marlowe, Jean's caregiver, won an important ruling in state court, where he was facing state marijuana charges. The judge threw out all evidence obtained with the search warrant, ruling that the informant used by the Polk County Sheriff's Department was "not a credible witness" and that they had acted with "willful intent, or with reckless disregard for the law" in using this informant as a basis for their search warrant. As a result, all charges were dismissed later that day.
By the end of the week, the District Attorney had ordered the sheriff to return all property taken from the Marlowes, except for the marijuana. This was the third time law enforcement has been ordered to return equipment to the Marlowe home. ASAWNC made sure news media was on hand to cover the return of property.
For more about ASAWNC, see their videos on YouTube at
www.youtube.com/asawnc and www.youtube.com/marloweism.
RESEARCH UPDATES
Cannabinoids Fight Non-Hodgkin Lymphoma Tumor Growth
Swedish researchers report success using the endocannabinoid system to fight non-Hodgkin lymphoma.
The findings, published in the International Journal of Cancer, show that a cannabinoid agonist halts the spread and growth of cancerous tumors in animals with non-Hodgkin lymphoma. Investigators report that mice treated with the cannabinoid agonist experienced a 40 percent reduction in tumor weight.
The researchers conclude that ability of cannabinoids to both restrict the proliferation of cancer cells and reprogram the cells to die off makes "the endocannabinoid system a potential new therapeutic target for individualized therapy in lymphomas."
These findings are consistent with earlier studies that have shown cannabinoids can halt the spread of many types of cancers, including brain, breast, lung, prostate and pancreatic cancers.
New Anti-inflammatory Compound Found in Cannabis
A new anti-inflammatory compound that is not psychoactive has been found in large concentrations in the cannabis plant. The compound, which can ease swelling, pain and inflammation, may lead to the development of new treatments for such diseases as rheumatoid arthritis, multiple sclerosis and Crohn's disease.
The chemical, called beta-caryophyllene, helps combat inflammation without affecting the brain. Researchers demonstrated in an animal study that beta-caryophyllene attaches to CB-2 cannabinoid receptors, producing the anti-inflammatory effect, but not to the CB-1 receptors, which are associated with the psychoactive effects of THC and other cannabinoids.
Analysis of cannabis has found it to contain as much as 35% beta-caryophyllene. Other common plants that contain the oil include black pepper, oregano, basil, lime, cinnamon, carrots, and celery.
Clinical Neuropathy Trial Shows Cannabis Effective
Even low doses of smoked cannabis can be effective in managing hard-to-treat neuropathic pain, according to California researchers. Investigators found that low- and high-dose cannabis produced similar levels of pain relief, reducing both the intensity and unpleasantness of the often unbearable nerve pain.
The researchers note that cannabis not only fights pain itself but also interacts with opiod painkillers to increase their effectiveness, particularly in neuropathic pain. They also note that using isolated synthetic cannabinoids such as THC (dronabinol) does not provide the same degree of efficacy as a whole-plant preparation of cannabis.
In conclusion, investigators observe that "cannabis does not rely on a relaxing or tranquillizing effect but rather reduces both the core component of nociception [the nerve transmission of pain] and the emotional aspect of the pain experience to an equal degree."
Case Studies Show THC Can Relieve Depression
While many patients report cannabis use has a positive impact on mental health issues ranging from anxiety to depression, such use is controversial and rarely studied. A recent pair of case studies from Austria, published last month in the journal of the International Association for Cannabis as Medicine, describe oral administration of synthetic THC (dronabinol) helping two women with chronic depression. The author reports that 8 out of 10 depressive patients he has treated with synthetic THC exhibited "swift improvement." He concludes that clinical studies of the "effectiveness of cannabinoids for the treatment of depression ⦠are desirable and promising."
NATIONAL ACTION ALERT
Defend Patients and Caregivers, Tell Congress to Stop Funding Medical Marijuana Raids Today!
It's time to stop wasting taxpayer dollars on raiding state-licensed patients and providers. Congress can do it. The Hinchey-Rohrabacher amendment to the Commerce-Justice-State appropriations bill instructs the Department of Justice to use its money wisely and specifically prohibits the Department from using appropriated funds to conduct raids or otherwise prevent the various states from implementing laws that authorize the therapeutic use of cannabis.
Tell your U.S. Representative that, if adopted, this amendment will do two things:
(1) Conserve taxpayers' money by eliminating funding for DEA raids aimed at state-certified medical cannabis patients and caregivers.
(2) Protect legal medical cannabis patients from having their homes and workspaces raided by the DEA.
For phone numbers of your representatives go to: www.house.gov or call the congressional switchboard at: (202) 224-3121.
Or contact George@AmericansforSafeAccess for additional info.
Fresno Supervisors to Hold Hearing on Medical Marijuana ID Card Program July 8

FOR IMMEDIATE RELEASEÂ Â Â
JULY 3, 2008
CONTACT: Aaron Smith, MPP California organizer, 707-575-9870
FRESNO, Calif. â The Fresno County Board of Supervisors will conduct a public hearing on the local implementation of the statewide Medical Marijuana Identification Card Program, 9 a.m., July 8, in the County Board Chambers in the Hall of Records at 2281 Tulare St.
   Although 40 California counties have implemented the program â including Merced, Tulare, Inyo and San Benito as well as Los Angeles, Orange and Kern â Fresno has yet to act.
   Patients and advocates from across the county, including Diana Kirby, 66, will attend the hearing. Kirby uses physician-approved medical marijuana, under state law, to treat severe pain from an auto accident that resulted in having her leg amputated.
   "Patients like me shouldn't have to worry about being falsely arrested because our county isn't offering the ID cards," Kirby said. "Let's hope our elected officials do the right thing for patients and taxpayers by implementing this program."
   Aaron Smith, California organizer for the Marijuana Policy Project, noted that the program â mandated by a state law that went into effect in 2004 â benefits law enforcement by removing the burden of verifying patient documentation from officers on the street. The ID card provides a means for local peace officers to easily identify bona fide medical marijuana patients during enforcement stops.
   "We are merely calling on the Board of Supervisors to follow existing state law so that suffering patients like Diana do not have to live in fear of false arrest at the expense of local taxpayers," Smith said. "It is the duty of the county's leaders to protect their most vulnerable citizens and to make the jobs of local law enforcement easier by providing them with all the tools available. This program is a major step in the right direction."
   To help educate the community about this and other medical marijuana issues facing Fresno, MPP will host a free screening of the award-winning medical marijuana documentary "Waiting to Inhale," followed by a panel discussion, July 7, at 7 p.m. at the Unitarian Universalist Church at 2672 E. Alluvial Ave., in Clovis.
   With more than 25,000 members and 100,000 e-mail subscribers nationwide, the Marijuana Policy Project is the largest marijuana policy reform organization in the United States. MPP believes that the best way to minimize the harm associated with marijuana is to regulate marijuana in a manner similar to alcohol. For more information, please visit www.MarijuanaPolicy.org.
Law Enforcement Against Prohibition: The LEAP Report July 2008
The Sentencing Project: Disenfranchisement News/Updates 7/03/08
Drug Truth 07/03/08 + John Stossel on Next COL
2008 NORML Conference Announced - Call for Speakers and Panel Suggestions
International Drug Policy Consortium Supplemental Alert - June 2008
Recurso: Se puede acceder al Calendario del Reformador a través de la página web de la DRCNet
Recurso: La página web de la DRCNet ofrece una gran cantidad de feeds RSS a su lector
Webmasters: ¡Ayude el movimiento poniendo feeds de agregación de la DRCNet en su página web!
Pagination
- First page
- Previous page
- …
- 850
- 851
- 852
- 853
- 854
- …
- Next page
- Last page